Does high-dose IV vitamin C help against cancer?
High-dose IV vitamin C: the strongest surprise in our library
The bottom line Promising
This is the strongest surprise in our library. In a small randomized trial, adding high-dose IV vitamin C to chemotherapy doubled survival in advanced pancreatic cancer (16 vs 8.3 months, 34 patients). That is genuinely promising — and far from proven: it awaits bigger trials, one prostate-cancer trial was negative, and every encouraging result came alongside chemotherapy, never instead of it. Vitamin C pills cannot reach these blood levels.
Here because of a specific diagnosis? This topic appears in our guides to: Pancreatic Cancer · Lung Cancer · Glioblastoma · Prostate Cancer
What it is — and why pills don't count
At very high blood concentrations — reachable only by infusion into a vein — vitamin C stops acting like a vitamin and starts acting like a drug: it generates hydrogen peroxide in tissues, which cancer cells handle far worse than healthy cells. Swallowed vitamin C can never reach those levels — your gut caps the absorption. This detail untangles decades of confusion: the famous 1980s Mayo Clinic trials that “disproved vitamin C” tested pills — so the IV question remained genuinely open [7].
What the evidence says
- The headline result: University of Iowa researchers ran a randomized trial in 34 patients with stage IV pancreatic cancer — one of the hardest cancers there is. Adding 75 grams of IV vitamin C three times a week to standard chemotherapy roughly doubled median survival: 16 months versus 8.3, and delayed progression (6.2 vs 3.9 months) [1][2]. Pancreatic survival numbers this different are rare enough that oncologists noticed.
- Why we still say “promising”, not “proven”: 34 patients is small; medicine has been burned by small trials before. A definitive larger trial is needed, and until it reads out, no guideline will — or should — change.
- Supporting signals: a 38-patient lung-cancer trial (no control group) saw better response rates than historical expectations [3]; glioblastoma studies (safety trial + a 55-patient study against historical controls) point the same cautious way [4][5].
- And an honest negative: a randomized, placebo-controlled trial in 47 men with advanced prostate cancer found no benefit at all [6]. Whatever IV vitamin C does, it is not universal.
- The official position: the National Cancer Institute's summary calls the evidence limited to small trials; the FDA has not approved IV vitamin C for cancer, and major centers class it as an investigational drug for trial settings [7][8].
What patients report — and the drip-bar problem
IV vitamin C is sold at countless private “infusion clinics”, often at $100–300 per drip. Know the difference: trial patients were screened (G6PD, kidneys), received precise pharmacological doses timed with chemotherapy, and were monitored. A wellness drip is none of those things. If you've had IV vitamin C during treatment, tell us how it went: .
Safety and interactions
- G6PD deficiency (a common inherited enzyme difference): high-dose vitamin C can trigger severe red-blood-cell destruction. Every trial screens for it first — any legitimate provider will too [8].
- Kidneys: vitamin C becomes oxalate; kidney disease, prior stones, or dialysis are contraindications — kidney failure has been reported [7][8].
- Glucose meters: high-dose vitamin C makes finger-prick meters read falsely high — a diabetic dosing insulin off a false reading can be seriously harmed [8].
- Drug interactions: may reduce the effect of some drugs (notably bortezomib, used in myeloma) — tell your full team [8].
- In trials, side effects were otherwise mild (thirst, urination from the fluid load) [1][7].
If you want to pursue it
The gold route is a clinical trial — ask your oncologist or ask us to search for IV vitamin C trials recruiting for your cancer type. Outside a trial, bring it to your oncology team first: proper screening (G6PD, kidney function), human-grade dosing, and coordination with your chemo schedule are what separates the published results from a wellness drip. It accompanies treatment; it never replaces it.
Common questions
Can I just take high-dose vitamin C pills instead?
No. Your gut caps absorption, so pills can't reach the blood levels that act on cancer cells — and the rigorous trials of pills were negative.
Should I get IV vitamin C instead of chemo?
No. Every encouraging result, including the doubled survival in pancreatic cancer, came from vitamin C added to chemotherapy — never replacing it.
Is it safe?
In trials, yes — after screening. It is dangerous with G6PD deficiency or kidney problems, and it distorts glucose meters, which matters for diabetics.
If survival doubled, why isn't this standard care?
Because 34 patients is a small trial. Medicine confirms results of this size before changing practice — larger trials are the next step, and we'll update this page as they report.
Sources
- TrialBodeker K.L. et al. Randomized phase 2: pharmacological ascorbate with gemcitabine/nab-paclitaxel in metastatic pancreatic cancer — overall survival 16 vs 8.3 months. Redox Biology, 2024. doi.org · trial registry
- ContextUniversity of Iowa announcement of the pancreatic trial results, December 2024. uiowa.edu
- TrialFurqan M. et al. Phase 2: high-dose ascorbate with chemotherapy in advanced non-small-cell lung cancer (38 patients, single-arm). Redox Biology, 2022. sciencedirect.com
- TrialAllen B.G. et al. First-in-human phase 1: ascorbate with radiation and temozolomide in glioblastoma. Clinical Cancer Research, 2019. doi.org
- TrialPhase 2 ascorbate study in glioblastoma (55 patients, compared to historical controls). Journal of Neuro-Oncology, 2024. PubMed
- TrialRandomized placebo-controlled phase 2: IV vitamin C with docetaxel in metastatic prostate cancer — no benefit. Cancer Research Communications, 2024. aacrjournals.org
- NCINational Cancer Institute, PDQ “Intravenous Vitamin C”, Health Professional Version, updated May 2025. cancer.gov
- MSKMemorial Sloan Kettering, About Herbs: Vitamin C — investigational status, G6PD/kidney/glucose-meter warnings. mskcc.org
- TrialMa Y. et al. IV ascorbate with chemotherapy in ovarian cancer: reduced chemotherapy toxicity (pilot). Science Translational Medicine, 2014. science.org
Also graded
Turmeric / Curcumin
A real lab story, weak human evidence — and real interactions with chemo and tamoxifen.
Read the evidence → UnknownFenbendazole
The famous story, the retracted paper, and what's actually known. No human trial has ever tested it.
Read the evidence → UnknownCannabis & CBD
Proven for hard-to-treat chemo nausea. Not shown to treat cancer itself.
Read the evidence →